A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer-Reference-Cited by-同舟云学术

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer

Published:2002-06 Issue:6 Volume:13 Page:889-894
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

De Boer R.H.,Eisen T.G.,Ellis P.A.,Johnston S.R.D.,Walsh G.,Ashley S.,Smith I.E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/6/889/587425/mdf150.pdf

Reference22 articles.

1. Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose-intensity increase of CEF chemotherapy: A randomised study in patients with advanced breast cancer;Ardizzoni;Br J Cancer,1994

2. Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) support;Bissett;Br J Cancer,1995

3. An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naïve patients with locally advanced or metastatic breast cancer;Piccart;Ann Oncol,1995

4. Accelerated chemotherapy with high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF in locally advanced and metastatic breast cancer;Scinto;Ann Oncol,1995

5. Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer;Lalisang;J Clin Oncol,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer;Critical Reviews in Oncology/Hematology;2012-03

2. Interventions for preventing oral mucositis for patients with cancer receiving treatment;Cochrane Database of Systematic Reviews;2011-04-13

3. Interventions for preventing oral mucositis for patients with cancer receiving treatment;Cochrane Database of Systematic Reviews;2010-12-08

4. Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity;Cancer Immunology, Immunotherapy;2010-02-06

5. Interventions for preventing oral mucositis for patients with cancer receiving treatment;Cochrane Database of Systematic Reviews;2007-10-17